Antibiotic Susceptibility Evaluation of Group A Streptococcus Isolated from Children with Pharyngitis: A Study from

Shirin Sayyahfar1, Alireza Fahimzad2, Amir Naddaf3

  • 1Division of Pediatric Infectious Diseases, Departement of Pediatrics, Ali Asghar Children Hospital, Iran University of Medical Sciences, Tehran, Iran.

Infection & Chemotherapy
|January 21, 2016
PubMed

Insights

Group A Streptococcus (GAS) in Iranian children shows high resistance to erythromycin and azithromycin, necessitating careful antibiotic selection. Penicillin G remains effective, but local surveillance is crucial for optimal treatment strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Group A Streptococcus (GAS) pharyngitis is a common childhood infection.
  • Antibiotic resistance in GAS impacts treatment efficacy.
  • Evaluating local antibiotic susceptibility patterns is essential for guiding clinical practice.

Purpose of the Study:

  • To assess the antibiotic susceptibility of Group A Streptococcus (GAS) strains.
  • To determine resistance patterns to commonly prescribed antibiotics for GAS pharyngitis in children in Iran.

Main Methods:

  • Prospective study of children aged 3-15 with acute tonsillopharyngitis.
  • GAS identification using standard microbiological techniques and Lancefield grouping.
  • Antimicrobial susceptibility testing via disk diffusion and broth dilution methods.

Main Results:

  • 30% of 200 children had GAS-positive throat cultures.
  • All GAS isolates were susceptible to penicillin G.
  • High resistance rates observed for erythromycin (33.9%), azithromycin (57.6%), and clarithromycin (33.9%).
  • Significant resistance also noted for clindamycin (13.5%) and ofloxacin (32.2%).
  • 8.4% of strains showed resistance to rifampin.

Conclusions:

  • High GAS resistance to macrolides and other antibiotics necessitates judicious antibiotic use in Iran.
  • Physicians should be cautious with antibiotic prescriptions to mitigate rising resistance.
  • Continuous local surveillance is vital for identifying effective therapeutic options for GAS infections.
Abstract